Morphoea and Borrelia burgdorferi: Results from the Scottish Highlands in the context of the world literature

Journal of Clinical Pathology - Molecular Pathology

Volumn 55, Issue 6, 2002, Pages 374-378

  Goodlad, John R ^a   Davidson, M M ^b   Gordon, P ^b   Billington, R ^a   Ho Yen, D O ^b  

^a RAIGMORE HOSPITAL   (United Kingdom)

^b NHS HIGHLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA;

ARTICLE; BACTERIUM DETECTION; BORRELIA BURGDORFERI; CLINICAL ARTICLE; CONTROLLED STUDY; ENDEMIC DISEASE; HUMAN; HUMAN TISSUE; LYME DISEASE; MORPHEA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; BIOPSY; BORRELIA BURGDORFERI; CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; FEMALE; HUMANS; LYME DISEASE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SCLERODERMA, LOCALIZED; SCOTLAND;

EID: 0036903599     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.55.6.374     Document Type: Article

References (46)

1. Ashbrink E, Hovmark H. Successful cultivation of spirochetes from skin lesions of patients with erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Acta Pathot Microbiol Immunol Scand [B] 1985;93:161-3.
2. Hovmark A, Asbrink E, Olsson I. The spirochetal etiology of lymphadenosis benigna cutis solitara. Acta Derm Venereol 1986;66:479-84.
3. Burgdorfer W, Barbour AG, Hayes SF, et al. Lyme disease - A tick-borne spirochetosis? Science 1982;216:1317-19.
4. Mitchell PD, Reed KD, Vandermause MT, et al. Isolation of Borrelia burgdorferi from skin biopsy specimens of patients with erythema migrans. Am J Clin Pathol 1993;99:104-7.
5. Goodlad JR, Davidson MM, Hollowood K, et al. Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland. Am J Surg Pathol 2000;24:1279-85.
6. Weide B, Walz T, Garbe C. Is morphoea caused by Borrelia burgdorferi? A review. Br J Dermatol 2000;142:636-44.
7. Fujiwara H, Fujiwara K, Hashimoto K, et al. Detection of Borrelia burgdorferi DNA (B. garinii or B. afzelii) in morphoea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients. Arch Dermatol 1997;133:41-4.
8. Muhlemann MF, Wright DJM, Black C. Serology of Lyme disease. Lancet 1986;1:553-4.
9. Lupoli S, Cutler SJ, Stephens CO, et al. Lyme disease and localized scleroderma - No evidence for a common aetiology. Br J Rheumatol 1991;30:154-6.
10. Steere AC, Taylor E, McHugh GL, et al. The overdiagnosis of Lyme disease. JAMA 1993;269:1812-16.
11. Jaworsky C. Connective tissue diseases. In: Elder D, Elenitsas R, Jaworsky C, et al, eds. Lever's Histopathology of the Skin, 8th Ed. New York: Lippincott-Raven, 1997:253-85.
12. Davidson MM, Evans R, Ling CL, et al. Isolation of Borrelia burgdorferi from ticks in the Highlands of Scotland. J Med Microbiol 1999;48;59-65.
13. Petersen LS, Nelson AM, Su WP. Classification of morphoea (localized scleroderma). Mayo Clin Proc 1995;70:1068-76.
14. Aberer E, Stanek G, Er HM, et al. Evidence for spirochetal origin of circumscribed scleroderma (morphoea). Acta Derm Venereol 1987;67:225-31.
15. Aberer E, Kollegger H, Kristoferitsch W, et al. Neuroborreliosis in morphoea and lichen sclerosus et atrophicus. J Am Acad Dermatol 1988;19:820-5.
16. Aberer E, Klade H, Stanek G, et al. Borrelia burgdorferi and different types of morphoea. Dermatologica 1991;182:145-54.
17. Aberer E, Stanek G. Histological evidence for spirochetal origin of morphea and lichen sclerosus et atrophicus. Am J Dermatopathol 1987;9:374-9.
18. Breier F, Klade H, Stanek G, et al. Lymphoproliferative responses to Borrelia burgdorferi in circumscribed scleroderma. Br J Dermatol 1996;134:285-91.
19. Aberer E, Kerstan A, Klode H, et al. Heterogeneity of Borrelia burgdorferi in the skin. Am J Dermatopathol 1996;18:571-9.
20. Breier FH, Aberer E, Stanek G, et al. Isolation of Borrelia afzelii from circumscribed scleroderma. Br J Dermatol 1999;140:925-30.
21. Schempp C, Bocklage H, Lange R, et al. Further evidence for Borrelia burgdorferi infection in morphoea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol 1993;100:717-20.
22. Wienecke R, Schlupen EM, Zochling N, et al. No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma. J Invest Dermatol 1995;104:23-6.
23. Weide B, Schttek B, Klyscz T, et al. Morphoea is neither associated with features of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction. Br J Dermatol 2000;143:780-5.
24. Weber K, Prac-Mursic V, Reimers CD. Spirochaetes isolated from two patients with morphoea. Infection 1988;16:25-6.
25. Raguin G, Boisnic S, Souteyrand, et al. No evidence for a spirochetal arigin of localized scleroderma. Br J Dermatol 1992;127:218-20.
26. Meiss JF, Koopman R, van Bergen B, et al. No evidence for a relationship between Borrelia burgdorferi infection and old lesions of localized scleroderma. Arch Dermatol 1993;129:386-7.
27. Ranki A, Aavik E, Peterson P, et al. Successful amplification of DNA specific for finish Borrelia burgdorferi isolates in erythema chronicum migrans but not in scleroderma lesions. J Invest Dermatol 1994;102:339-45.
28. Alonso-Llamazares J, Persing DH, Anda P, et al. No evidence for Borrelia burgdorferi infection in lesions of morphoea and lichen sclerosus et atrophicus in Spain. A prospective study and literature review. Acta Derm Venereol 1997;77:299-304.
29. Trevisan G, Stinco G, Nobile C, et al. Detection of Borrelia burgdorferi in skin biopsies from patients with morphoea by polymerase chain reaction. J Eur Acad Dermatol Venereol 1996;6:15-19.
30. Buechner SA, Winklemann RK, Lautenschlager S, et al. Localized scleroderma associated with Borrelia burgdorferi infection. Clinical, histologic and immunohistochemical observations. J Am Acad Dermatol 1993;29:190-6.
31. Ozkan S, Atabey N, Fetil E, et al. Evidence for Borrelia burgdorferi in morphea and lichen sclerosus. Int J Dermatol 2000;39:278-83.
32. Ross SA, Sanchez JL, Taboas JO. Spirochetal forms in the dermal lesions of morphea and lichen sclerosus et atrophicus. Am J Dermatopathol 1990;12:357-62.
33. Daoud MS, Su WP, Leiferman KM, et al. Bullous morphea: Clinical, pathologic, and immunopathologic evaluation of thirteen cases. J Am Acad Dermatol 1994;30:937-43.
34. Fan W, Leonardi CL, Penneys NS. Absence of Borrelia burgdorferi in patients with localized scleroderma (morphea). J Am Acad Dermatol 1995;33:682-4.
35. Dillon WI, Saed GM, Fivenson DP. Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphoea, scleroderma, or lichen sclerosus et atrophicus of patients from North America. J Am Acad Dermatol 1995;33:617-20.
36. De Vito JR, Merogi AJ, Vo T, et al. Role of Borrelia burgdorferi in the pathogenesis of morphoea/scleroderma and lichen sclerosus et atrophicus: A PCR study of thirty-five cases. J Cutan Pathol 1996;23:350-8.
37. Colome-Grimmer MI, Payne DA, Tyring SK, et al. Borrelia burgdorferi DNA and Borrelia hermsii DNA are not associated with morphea or lichen sclerosus et atrophicus in the southwestern United States [letter]. Arch Dermatol 1997;133:1174.
38. Abele DC, Bedingfield RB, Chandler FW, et al. Progressive facial hemiatrophy (Parry-Romberg syndrome) and borreliosis. J Am Acad Dermatol 1990;22:531-3.
39. Asbrink E, Hovmark A, Olsen I. Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene/Reihe A 1986;263:253-61.
40. Asbrink E, Brehmer-Anderson E, Hovmark A. Acrodermatitis chronica atrophicans - A spirochaetosis. A clinical and histological picture based on 32 patients: Course and relationship to erythema chronicum migrans Afzelius. Am J Dematopathol 1986;8:209-19.
41. Nadelman RB, Wormser GP. Lyme borreliosis. Lancet 1998;352:557-65.
42. Ho-Yen DO, Davidson MM, Joss AWL. How prevalent is Lyme disease in Scotland? SCIEH Weekly Report 1999;33:214-15.
43. Ling CL, Joss AWL, Davidson MM, et al. Identification of different Borrelia burgdorferi genomic groups from Scottish ticks. Mol Pathol 2000;53:94-8.
44. Wang G, van Dam AP, Spanjaard L, et al. Molecular typing of Borrelia burgdorferi sensu lato by random amplified polymorphic DNA fingerprinting analysis. J Clin Microbiol 1998;36:768-77.
45. Mathiesen DA, Oliver JH, Jr, Kalbert CP, et al. Genetic heterogeneity of Borrelia burgdorferi in the United States. J Infect Dis 1997;175:98-107.
46. Junttila J, Peltomaa M, Soini H, et al. Prevalence of Borrelia burgdorferi in Ixodes ricinus ticks in urban recreational areas of Helsinki. J Clin Microbiol 1999;37:1361-5.